First Trust Nasdaq Pharmaceuticals ETFNASDAQ:FTXH
- LAST PRICE27.10
- TODAY'S CHANGE (%)-0.89 (-3.18%)
- Bid / Lots24.63/ 1
- Ask / Lots27.95/ 1
- Open / Previous Close27.48 / 27.99
- Day Range
- 52 Week Range
- Volume8,412
- Overall Morningstar Rating3 out of 5 Starsout of 268 funds
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | FTXH |
|---|---|---|
| 09:44 ET | 1581 | 27.48 |
| 10:02 ET | 222 | 27.39 |
| 10:13 ET | 1669 | 27.26 |
| 10:47 ET | 1277 | 27.2 |
| 11:14 ET | 177 | 27.25 |
| 01:24 ET | 2000 | 27.25 |
| 02:12 ET | 100 | 27.18 |
| 02:32 ET | 100 | 27.16 |
| 04:00 ET | 100 | 27.1 |
Daily Premium/Discount
| Date | Daily Premium/Discount |
|---|---|
| 08/20/2024 | 0.01% |
| 08/21/2024 | -0.02% |
| 08/22/2024 Largest Premium | 0.14% |
| 08/23/2024 | -0.05% |
| 08/26/2024 | -0.06% |
| 08/27/2024 | -0.03% |
| 08/28/2024 | 0.06% |
| 08/29/2024 | -0.07% |
| 08/30/2024 | -0.05% |
| 09/03/2024 | -0.13% |
| 09/04/2024 | -0.03% |
| 09/05/2024 Largest Discount | -0.19% |
| 09/09/2024 | -0.10% |
| 09/10/2024 | -0.09% |
| 09/11/2024 | -0.10% |
| 09/12/2024 | -0.07% |
| 09/13/2024 | -0.07% |
| 09/16/2024 | -0.14% |
| 09/18/2024 | -0.03% |
| 09/19/2024 | -0.15% |
| 09/20/2024 | -0.07% |
| 09/23/2024 | -0.09% |
| 09/24/2024 | -0.05% |
| 09/25/2024 | 0.01% |
| 09/26/2024 | 0.03% |
| 09/27/2024 | 0.07% |
| 09/30/2024 | -0.01% |
| 10/01/2024 | -0.05% |
| 10/02/2024 | 0.02% |
| 10/03/2024 | -0.04% |
| 10/04/2024 | -0.03% |
| 10/07/2024 | 0.11% |
| 10/08/2024 | 0.04% |
| 10/09/2024 | 0.01% |
| 10/10/2024 | -0.04% |
| 10/11/2024 | 0.10% |
| 10/14/2024 | 0.03% |
| 10/15/2024 | -0.05% |
| 10/16/2024 | -0.17% |
| 10/17/2024 | -0.03% |
| 10/18/2024 | -0.17% |
| 10/21/2024 Largest Premium | 0.14% |
| 10/22/2024 | -0.18% |
| 10/23/2024 | -0.07% |
| 10/24/2024 | -0.02% |
| 10/25/2024 | -0.07% |
| 10/28/2024 | -0.02% |
| 10/29/2024 | -0.02% |
| 10/30/2024 | -0.02% |
| 10/31/2024 | 0.07% |
| 11/01/2024 | -0.08% |
| 11/04/2024 | -0.07% |
| 11/05/2024 | -0.11% |
| 11/06/2024 | -0.05% |
| 11/08/2024 | 0.06% |
| 11/11/2024 | -0.05% |
| 11/12/2024 | -0.05% |
| 11/13/2024 | -0.14% |
| 11/14/2024 | -0.07% |
| 11/15/2024 | -0.15% |
| US Stock | 99.4% |
|---|---|
| Non-US Stock | 0.5% |
| Cash | 0.1% |
| Convertible | 0 |
| Non-US Bond | 0 |
| Other | 0 |
| Healthcare | 99.9% |
|---|---|
| Basic Mat. | 0 |
| Communication Services | 0 |
| Consumer Cyclical | 0 |
| Consumer Defensive | 0 |
| Energy | 0 |
| Financial Serv.s | 0 |
| Industrials | 0 |
| Real Estate | 0 |
| Technology | 0 |
| Utilities | 0 |
| United States | 99.5% |
|---|---|
| Latin America | 0 |
| Africa | 0 |
| Asia/Oceania | 0 |
| Canada | 0 |
| Europe | 0 |
| Company Name sortable | Position sortable | Allocation sortable | Allocation sortable1 Month Change | Market Value sortable |
|---|---|---|---|---|
Bristol-Myers Squibb Co | Long | 8.4% | 0.00% | $1.4M |
AbbVie Inc | Long | 7.8% | 0.00% | $1.3M |
Pfizer Inc | Long | 7.3% | 0.00% | $1.2M |
Johnson & Johnson | Long | 7.3% | 0.00% | $1.2M |
Merck & Co Inc | Long | 6.5% | 0.00% | $1.1M |
Gilead Sciences Inc | Long | 4.2% | 0.00% | $716.2K |
United Therapeutics Corp | Long | 3.7% | 0.00% | $633.1K |
Zoetis Inc Class A | Long | 3.7% | 0.00% | $620.5K |
Cardinal Health Inc | Long | 3.6% | 0.00% | $613.2K |
Viatris Inc | Long | 3.6% | 0.00% | $611.7K |
Reports
- ManagedInvestmentETF11/10/24
Morningstar ETF Report
The Morningstar ETF Report offers in-depth analyst research on exchange-traded funds to help you evaluate these investments and how they fit within a portfolio.
Morningstar Ratings
| Time Horizon | Star Rating |
|---|---|
| Overall Rating | 3 out of 5 Stars |
| 3 Year Rating | 4 out of 5 Stars |
| 5 Year Rating | 3 out of 5 Stars |
| 10 Year Rating | Not Rated |
Past performance is no guarantee of future results. The ratings reflect historical risk-adjusted performance, and the overall rating is derived from a weight average of the fund's 3, 5, and 10 year (Morningstar Rating) metrics.
Style Box is calculated only using the long position holdings of the portfolio.
Best Fit Index | Nasdaq US Smart Pharmaceuticals TR USD |
|---|---|
Category | |
Sponsor | First Trust Advisors L.P. |
Inception | September 20, 2016 |
The investment seeks investment results that correspond generally to the price and yield (before the fund's fees and expenses) of the Nasdaq US Smart Pharmaceuticals TM Index. The fund will normally invest at least 90% of its net assets (including investment borrowings) in the securities that comprise the index. The index is designed to provide exposure to U.S. companies comprising the pharmaceutical sector that have been selected based upon their liquidity and ranking. It is non-diversified.
| Total Net Assets | $16.9M |
|---|---|
| Shares Out. | 600.0K |
| Net Asset Value (NAV) | $27.14 |
| Prem/Discount to NAV | -0.15% |
| P/E Ratio | 22.3 |
| Dividend Yield | 1.63% |
| Dividend per Share | 0.44 USD |
| Ex-Dividend Date | 09/26/2024 |
| Dividend Payment Date | 09/30/2024 |
| Beta | --- |
| Morningstar Investment Style | Health |
| Equity Style | Mid Cap Value |
| Credit Quality / Duration | --- |
| Actual Management Fee | 0.60% |
|---|---|
| Actual Mgmt. Expense Ratio (MER) | 0.60% |